APO Research
Talk to an analyst

APO RESEARCH · REPORT

Marek's Disease Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Marek's Disease Vaccine Industry Growth and Trends Forecast to 2032

2 January 2026108 pages

Choose your research edition.

Industry ResearchMarek's Disease Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Marek's Disease Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Marek's Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Marek's Disease Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Marek's Disease Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Marek's Disease Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Marek's Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Marek's Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Marek's Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Marek's Disease Vaccine include Boehringer Ingelheim, Ceva, Merial, Zoetis, Beijing Huadu Shihua Biological Products Co., Ltd., Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Guangxi Lichengdong Biological Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Marek's Disease Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Marek's Disease Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Marek's Disease Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Marek's Disease Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Marek's Disease Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Marek's Disease Vaccine Market by Company

Boehringer Ingelheim

Ceva

Merial

Zoetis

Beijing Huadu Shihua Biological Products Co., Ltd.

Guangdong Wen's Dahuanong Biotechnology Co., Ltd.

Guangxi Lichengdong Biological Co., Ltd.

Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

Merck

Ruipu Biopharmaceutical Co., Ltd.

Marek's Disease Vaccine Segment by Type

Bivalent Vaccine

Monovalent Vaccine

Marek's Disease Vaccine Segment by Application

Veterinary Pharmacy

Online Sale

Others

Marek's Disease Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marek's Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Marek's Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marek's Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Marek's Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Marek's Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Bivalent Vaccine Table 2. Major Company of Monovalent Vaccine Table 3. Global Marek's Disease Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Marek's Disease Vaccine Sales by Type (2021-2026) & (K Doses) Table 5. Global Marek's Disease Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Marek's Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Marek's Disease Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Marek's Disease Vaccine Price by Type (2021-2026) & (US$/Dose) Table 9. Global Marek's Disease Vaccine Sales by Type (2027-2032) & (K Doses) Table 10. Global Marek's Disease Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Marek's Disease Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Marek's Disease Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Marek's Disease Vaccine Price by Type (2027-2032) & (US$/Dose) Table 14. North America Marek's Disease Vaccine Sales by Type (2021-2026) & (K Doses) Table 15. North America Marek's Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Marek's Disease Vaccine Sales by Type (2021-2026) & (K Doses) Table 17. Europe Marek's Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Marek's Disease Vaccine Sales by Type (2021-2026) & (K Doses) Table 19. Asia-Pacific Marek's Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Marek's Disease Vaccine Sales by Type (2021-2026) & (K Doses) Table 21. Latin America Marek's Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Marek's Disease Vaccine Sales by Type (2021-2026) & (K Doses) Table 23. Middle East and Africa Marek's Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Marek's Disease Vaccine Industry Trends Table 25. Marek's Disease Vaccine Industry Drivers Table 26. Marek's Disease Vaccine Industry Opportunities and Challenges Table 27. Marek's Disease Vaccine Industry Restraints Table 28. Global Marek's Disease Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Marek's Disease Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Marek's Disease Vaccine Sales by Company (2021-2026) & (K Doses) Table 31. Global Marek's Disease Vaccine Sales Share by Company (2021-2026) Table 32. Global Marek's Disease Vaccine Market Price by Company (2021-2026) & (US$/Dose) Table 33. Global Marek's Disease Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Marek's Disease Vaccine Major Company Production Sites and Headquarters Table 35. Global Marek's Disease Vaccine Company, Product Type & Application Table 36. Global Marek's Disease Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Marek's Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Marek's Disease Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Marek's Disease Vaccine Sales by Region (2021-2026) & (K Doses) Table 41. Global Marek's Disease Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Marek's Disease Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Marek's Disease Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Marek's Disease Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 45. Global Marek's Disease Vaccine Sales by Region (2027-2032) & (K Doses) Table 46. Global Marek's Disease Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Marek's Disease Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Marek's Disease Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Marek's Disease Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2027-2032) Table 50. Global Marek's Disease Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Marek's Disease Vaccine Sales by Application (2021-2026) & (K Doses) Table 52. Global Marek's Disease Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Marek's Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Marek's Disease Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Marek's Disease Vaccine Price by Application (2021-2026) & (US$/Dose) Table 56. Global Marek's Disease Vaccine Sales by Application (2027-2032) & (K Doses) Table 57. Global Marek's Disease Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Marek's Disease Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Marek's Disease Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Marek's Disease Vaccine Price by Application (2027-2032) & (US$/Dose) Table 61. North America Marek's Disease Vaccine Sales by Application (2021-2026) & (K Doses) Table 62. North America Marek's Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Marek's Disease Vaccine Sales by Application (2021-2026) & (K Doses) Table 64. Europe Marek's Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Marek's Disease Vaccine Sales by Application (2021-2026) & (K Doses) Table 66. Asia-Pacific Marek's Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Marek's Disease Vaccine Sales by Application (2021-2026) & (K Doses) Table 68. Latin America Marek's Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Marek's Disease Vaccine Sales by Application (2021-2026) & (K Doses) Table 70. Middle East and Africa Marek's Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Marek's Disease Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Marek's Disease Vaccine Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. Ceva Company Information Table 77. Ceva Business Overview Table 78. Ceva Marek's Disease Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 79. Ceva Marek's Disease Vaccine Product Portfolio Table 80. Ceva Recent Development Table 81. Merial Company Information Table 82. Merial Business Overview Table 83. Merial Marek's Disease Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 84. Merial Marek's Disease Vaccine Product Portfolio Table 85. Merial Recent Development Table 86. Zoetis Company Information Table 87. Zoetis Business Overview Table 88. Zoetis Marek's Disease Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 89. Zoetis Marek's Disease Vaccine Product Portfolio Table 90. Zoetis Recent Development Table 91. Beijing Huadu Shihua Biological Products Co., Ltd. Company Information Table 92. Beijing Huadu Shihua Biological Products Co., Ltd. Business Overview Table 93. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 94. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 95. Beijing Huadu Shihua Biological Products Co., Ltd. Recent Development Table 96. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information Table 97. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Business Overview Table 98. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 99. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 100. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Development Table 101. Guangxi Lichengdong Biological Co., Ltd. Company Information Table 102. Guangxi Lichengdong Biological Co., Ltd. Business Overview Table 103. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 104. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 105. Guangxi Lichengdong Biological Co., Ltd. Recent Development Table 106. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information Table 107. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview Table 108. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 109. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 110. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Development Table 111. Merck Company Information Table 112. Merck Business Overview Table 113. Merck Marek's Disease Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 114. Merck Marek's Disease Vaccine Product Portfolio Table 115. Merck Recent Development Table 116. Ruipu Biopharmaceutical Co., Ltd. Company Information Table 117. Ruipu Biopharmaceutical Co., Ltd. Business Overview Table 118. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 119. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 120. Ruipu Biopharmaceutical Co., Ltd. Recent Development Table 121. North America Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 122. North America Marek's Disease Vaccine Sales by Country (2021-2026) & (K Doses) Table 123. North America Marek's Disease Vaccine Sales Market Share by Country (2021-2026) Table 124. North America Marek's Disease Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 125. North America Marek's Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 126. North America Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Marek's Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Marek's Disease Vaccine Market Share by Country (2021-2026) Table 129. North America Marek's Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Marek's Disease Vaccine Market Share Forecast by Country (2027-2032) Table 131. Europe Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 132. Europe Marek's Disease Vaccine Sales by Country (2021-2026) & (K Doses) Table 133. Europe Marek's Disease Vaccine Sales Market Share by Country (2021-2026) Table 134. Europe Marek's Disease Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 135. Europe Marek's Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Marek's Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Marek's Disease Vaccine Market Share by Country (2021-2026) Table 139. Europe Marek's Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Marek's Disease Vaccine Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Marek's Disease Vaccine Sales by Country (2021-2026) & (K Doses) Table 143. Asia-Pacific Marek's Disease Vaccine Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Marek's Disease Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 145. Asia-Pacific Marek's Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Marek's Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Marek's Disease Vaccine Market Share by Country (2021-2026) Table 149. Asia-Pacific Marek's Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Marek's Disease Vaccine Market Share Forecast by Country (2027-2032) Table 151. Latin America Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 152. Latin America Marek's Disease Vaccine Sales by Country (2021-2026) & (K Doses) Table 153. Latin America Marek's Disease Vaccine Sales Market Share by Country (2021-2026) Table 154. Latin America Marek's Disease Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 155. Latin America Marek's Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Marek's Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Marek's Disease Vaccine Market Share by Country (2021-2026) Table 159. Latin America Marek's Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Marek's Disease Vaccine Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Marek's Disease Vaccine Sales by Country (2021-2026) & (K Doses) Table 163. Middle East and Africa Marek's Disease Vaccine Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Marek's Disease Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 165. Middle East and Africa Marek's Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Marek's Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Marek's Disease Vaccine Market Share by Country (2021-2026) Table 169. Middle East and Africa Marek's Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Marek's Disease Vaccine Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Marek's Disease Vaccine Distributors List Table 174. Marek's Disease Vaccine Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Marek's Disease Vaccine Image Figure 2. Global Marek's Disease Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Marek's Disease Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Marek's Disease Vaccine Sales (2021-2032) & (K Doses) Figure 5. Bivalent Vaccine Image Figure 6. Global Bivalent Vaccine Sales YoY Growth (2021-2032) & (K Doses) Figure 7. Monovalent Vaccine Image Figure 8. Global Monovalent Vaccine Sales YoY Growth (2021-2032) & (K Doses) Figure 9. Global Marek's Disease Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Marek's Disease Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Marek's Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Marek's Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Marek's Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Marek's Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Marek's Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Marek's Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Marek's Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Marek's Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Marek's Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Marek's Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Marek's Disease Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Veterinary Pharmacy Image Figure 24. Global Veterinary Pharmacy Sales YoY Growth (2021-2032) & (K Doses) Figure 25. Online Sale Image Figure 26. Global Online Sale Sales YoY Growth (2021-2032) & (K Doses) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Doses) Figure 29. Global Marek's Disease Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Marek's Disease Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Marek's Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Marek's Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Marek's Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Marek's Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Marek's Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Marek's Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Marek's Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Marek's Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Marek's Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Marek's Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Marek's Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 42. North America Marek's Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Marek's Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Marek's Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Marek's Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 46. Europe Marek's Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Marek's Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Marek's Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Marek's Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 50. Asia-Pacific Marek's Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Marek's Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Marek's Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Marek's Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 54. Latin America Marek's Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Marek's Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Marek's Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Marek's Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 58. Middle East and Africa Marek's Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Marek's Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Marek's Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Marek's Disease Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Marek's Disease Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Bivalent Vaccine
  • Monovalent Vaccine
Applications
  • Veterinary Pharmacy
  • Online Sale
  • Others
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Merial
  • Zoetis
  • Beijing Huadu Shihua Biological Products Co., Ltd.
  • Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
  • Guangxi Lichengdong Biological Co., Ltd.
  • Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
  • Merck
  • Ruipu Biopharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Marek's Disease Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Marek's Disease Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Marek's Disease Vaccine Market by Type
  6. 1.3.1 Bivalent Vaccine
  7. 1.3.2 Monovalent Vaccine
  8. 1.4 Global Marek's Disease Vaccine Market Size by Type
  9. 1.4.1 Global Marek's Disease Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Marek's Disease Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Marek's Disease Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Marek's Disease Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Marek's Disease Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Marek's Disease Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Marek's Disease Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Marek's Disease Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Marek's Disease Vaccine Industry Trends
  2. 2.2 Marek's Disease Vaccine Industry Drivers
  3. 2.3 Marek's Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Marek's Disease Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Marek's Disease Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Marek's Disease Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Marek's Disease Vaccine Price (2021-2026)
  4. 3.4 Global Marek's Disease Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Marek's Disease Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Marek's Disease Vaccine Company, Product Type & Application
  7. 3.7 Global Marek's Disease Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Marek's Disease Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Marek's Disease Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Marek's Disease Vaccine Tier 1, Tier 2, and Tier 3
4 Marek's Disease Vaccine Regional Status and Outlook
  1. 4.1 Global Marek's Disease Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Marek's Disease Vaccine Historic Market Size by Region
  3. 4.2.1 Global Marek's Disease Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Marek's Disease Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Marek's Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Marek's Disease Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Marek's Disease Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Marek's Disease Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Marek's Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Marek's Disease Vaccine by Application
  1. 5.1 Marek's Disease Vaccine Market by Application
  2. 5.1.1 Veterinary Pharmacy
  3. 5.1.2 Online Sale
  4. 5.1.3 Others
  5. 5.2 Global Marek's Disease Vaccine Market Size by Application
  6. 5.2.1 Global Marek's Disease Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Marek's Disease Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Marek's Disease Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Marek's Disease Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Marek's Disease Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Marek's Disease Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Marek's Disease Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Marek's Disease Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Marek's Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Marek's Disease Vaccine Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Ceva
  8. 6.2.1 Ceva Company Information
  9. 6.2.2 Ceva Business Overview
  10. 6.2.3 Ceva Marek's Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ceva Marek's Disease Vaccine Product Portfolio
  12. 6.2.5 Ceva Recent Developments
  13. 6.3 Merial
  14. 6.3.1 Merial Company Information
  15. 6.3.2 Merial Business Overview
  16. 6.3.3 Merial Marek's Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merial Marek's Disease Vaccine Product Portfolio
  18. 6.3.5 Merial Recent Developments
  19. 6.4 Zoetis
  20. 6.4.1 Zoetis Company Information
  21. 6.4.2 Zoetis Business Overview
  22. 6.4.3 Zoetis Marek's Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zoetis Marek's Disease Vaccine Product Portfolio
  24. 6.4.5 Zoetis Recent Developments
  25. 6.5 Beijing Huadu Shihua Biological Products Co., Ltd.
  26. 6.5.1 Beijing Huadu Shihua Biological Products Co., Ltd. Company Information
  27. 6.5.2 Beijing Huadu Shihua Biological Products Co., Ltd. Business Overview
  28. 6.5.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolio
  30. 6.5.5 Beijing Huadu Shihua Biological Products Co., Ltd. Recent Developments
  31. 6.6 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
  32. 6.6.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information
  33. 6.6.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Business Overview
  34. 6.6.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolio
  36. 6.6.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Developments
  37. 6.7 Guangxi Lichengdong Biological Co., Ltd.
  38. 6.7.1 Guangxi Lichengdong Biological Co., Ltd. Company Information
  39. 6.7.2 Guangxi Lichengdong Biological Co., Ltd. Business Overview
  40. 6.7.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolio
  42. 6.7.5 Guangxi Lichengdong Biological Co., Ltd. Recent Developments
  43. 6.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
  44. 6.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
  45. 6.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview
  46. 6.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolio
  48. 6.8.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments
  49. 6.9 Merck
  50. 6.9.1 Merck Company Information
  51. 6.9.2 Merck Business Overview
  52. 6.9.3 Merck Marek's Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck Marek's Disease Vaccine Product Portfolio
  54. 6.9.5 Merck Recent Developments
  55. 6.10 Ruipu Biopharmaceutical Co., Ltd.
  56. 6.10.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Ruipu Biopharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolio
  60. 6.10.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Marek's Disease Vaccine Sales by Country
  2. 7.1.1 North America Marek's Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Marek's Disease Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Marek's Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Marek's Disease Vaccine Market Size by Country
  6. 7.2.1 North America Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Marek's Disease Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Marek's Disease Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Marek's Disease Vaccine Sales by Country
  2. 8.1.1 Europe Marek's Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Marek's Disease Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Marek's Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Marek's Disease Vaccine Market Size by Country
  6. 8.2.1 Europe Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Marek's Disease Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Marek's Disease Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Marek's Disease Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Marek's Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Marek's Disease Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Marek's Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Marek's Disease Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Marek's Disease Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Marek's Disease Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Marek's Disease Vaccine Sales by Country
  2. 10.1.1 South America Marek's Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Marek's Disease Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Marek's Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Marek's Disease Vaccine Market Size by Country
  6. 10.2.1 South America Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Marek's Disease Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Marek's Disease Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Marek's Disease Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Marek's Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Marek's Disease Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Marek's Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Marek's Disease Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Marek's Disease Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Marek's Disease Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Marek's Disease Vaccine Value Chain Analysis
  2. 12.1.1 Marek's Disease Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Marek's Disease Vaccine Production Mode & Process
  7. 12.2 Marek's Disease Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Marek's Disease Vaccine Distributors
  10. 12.2.3 Marek's Disease Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst